Jeil Pharma Holdings Inc
Simbol: 002620.KS
KSC
10560
KRWPrețul de piață astăzi
-20.3172
Raportul P/E
0.0956
Raportul PEG
162.11B
MRK Cap
- 0.00%
Randament DIV
Jeil Pharma Holdings Inc (002620-KS) Situații financiare
Bilanț
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 234375.12 | 59131 | 53402.7 | 47223.7 | |||||||||||||||||
balance-sheet.row.short-term-investments | 86457.8 | 22092.4 | 18643.2 | 18642.9 | |||||||||||||||||
balance-sheet.row.net-receivables | 782964.19 | 198695.1 | 181304.5 | 167949 | |||||||||||||||||
balance-sheet.row.inventory | 531549.74 | 125280.1 | 113265.7 | 114242.9 | |||||||||||||||||
balance-sheet.row.other-current-assets | 11507.57 | 1421 | 4943.5 | 5728.2 | |||||||||||||||||
balance-sheet.row.total-current-assets | 1560396.62 | 384527.2 | 352916.4 | 335143.7 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 921883.08 | 228862.4 | 233120.1 | 212965.1 | |||||||||||||||||
balance-sheet.row.goodwill | 265259.92 | 44862.3 | 73465.9 | 151801.2 | |||||||||||||||||
balance-sheet.row.intangible-assets | 48297.94 | 13093.2 | 9472.3 | 3781.3 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 313557.86 | 57955.5 | 82938.2 | 155582.5 | |||||||||||||||||
balance-sheet.row.long-term-investments | 389896.62 | 199929.7 | 67118.8 | 60379.6 | |||||||||||||||||
balance-sheet.row.tax-assets | -64449.59 | 5448.7 | 188.5 | 1451.9 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 470872.57 | 3273.5 | 129395.1 | 126898.6 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 2031760.54 | 495469.8 | 512760.6 | 557277.7 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 3592157.16 | 879997 | 865677 | 892421.4 | |||||||||||||||||
balance-sheet.row.account-payables | 636258.45 | 154050 | 162967.4 | 159388.3 | |||||||||||||||||
balance-sheet.row.short-term-debt | 600673.06 | 161332.5 | 119087.3 | 94964.5 | |||||||||||||||||
balance-sheet.row.tax-payables | 3382.6 | 774.7 | 1159.8 | 684.8 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 49892.41 | 10500 | 17477 | 20107.5 | |||||||||||||||||
Deferred Revenue Non Current | 9246.16 | 1198 | 0 | 36229.2 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 145216.43 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 205023.86 | 95305.2 | 74662 | 17971.9 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 262882.12 | 65175.1 | 87379.8 | 94084.1 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 6892.95 | 1198 | 1869.2 | 2383.2 | |||||||||||||||||
balance-sheet.row.total-liab | 1882055.08 | 477810.9 | 445884.6 | 392107.7 | |||||||||||||||||
balance-sheet.row.preferred-stock | 43492.24 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 31946.71 | 7986.7 | 7986.7 | 7986.7 | |||||||||||||||||
balance-sheet.row.retained-earnings | 309763.33 | -14357.5 | 98244.6 | 172151.3 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 477369.96 | 152732.4 | 226471 | 226109.7 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 498974.16 | 173099.5 | 5062.4 | 5482.9 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1361546.4 | 319461.2 | 337764.7 | 411730.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 3592157.16 | 879997 | 865677 | 892421.4 | |||||||||||||||||
balance-sheet.row.minority-interest | 348555.67 | 82724.9 | 82027.8 | 88583.2 | |||||||||||||||||
balance-sheet.row.total-equity | 1710102.08 | 402186.1 | 419792.5 | 500313.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 3592157.16 | - | - | - | |||||||||||||||||
Total Investments | 476354.42 | 222022.1 | 85761.9 | 79022.5 | |||||||||||||||||
balance-sheet.row.total-debt | 651763.51 | 173030.5 | 136564.4 | 115072 | |||||||||||||||||
balance-sheet.row.net-debt | 503846.19 | 135991.9 | 101804.9 | 86491.2 |
Situația fluxurilor de numerar
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -11642.57 | -16249.7 | -83145 | -12870 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 12556.11 | 12556.1 | 10905.1 | 8983.2 | |||||||||||||||||
cash-flows.row.deferred-income-tax | -8558.55 | -60632 | 0 | -664 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 578.03 | 578 | 472.5 | 163.2 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -28544.09 | -28544.1 | -22115.2 | 14405.2 | |||||||||||||||||
cash-flows.row.account-receivables | -12922.7 | -12922.7 | -14120.2 | 8024.7 | |||||||||||||||||
cash-flows.row.inventory | -12170.48 | -12170.5 | 1347.3 | 9341.5 | |||||||||||||||||
cash-flows.row.account-payables | -9848.6 | -9848.6 | 3357.5 | 10023.5 | |||||||||||||||||
cash-flows.row.other-working-capital | 6397.69 | 6397.7 | -12699.8 | -12984.4 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 31195.44 | 87876.1 | 73080.5 | 3385.4 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -4415.63 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -9909.58 | -9836.6 | -21410 | -23736.1 | |||||||||||||||||
cash-flows.row.acquisitions-net | 87.64 | 87.6 | 24 | -1500 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -3775.84 | -3769.8 | -0.3 | -10005.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 169.7 | 999.5 | |||||||||||||||||
cash-flows.row.other-investing-activites | 172.76 | 93.8 | 3652.9 | 41567.1 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -13425.02 | -13425 | -17563.7 | 7325.1 | |||||||||||||||||
cash-flows.row.debt-repayment | -31854.19 | -22634.4 | -5156.3 | -6125 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 7497.6 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -397 | -31210.2 | |||||||||||||||||
cash-flows.row.dividends-paid | -362 | -1133.9 | -1474.9 | -1590 | |||||||||||||||||
cash-flows.row.other-financing-activites | 54328.13 | 44384.3 | 51942.1 | 19190 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 20616.07 | 20616.1 | 44914 | -12237.6 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -496.29 | -496.3 | -369.4 | -93.2 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 2279.12 | 2279.1 | 6178.7 | 8397.4 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 147917.32 | 37038.6 | 34759.5 | 28580.8 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 145638.2 | 34759.5 | 28580.8 | 20183.4 | |||||||||||||||||
cash-flows.row.operating-cash-flow | -4415.63 | -4415.6 | -20802.2 | 13403.1 | |||||||||||||||||
cash-flows.row.capital-expenditure | -9909.58 | -9836.6 | -21410 | -23736.1 | |||||||||||||||||
cash-flows.row.free-cash-flow | -14325.21 | -14252.3 | -42212.2 | -10333.1 |
Rândul din contul de profit și pierdere
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 801550.85 | 794713.6 | 792964.7 | 762568.1 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 590068.68 | 592891.6 | 612481.6 | 582061.3 | |||||||||||||||||
income-statement-row.row.gross-profit | 211482.17 | 201822 | 180483.1 | 180506.8 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 45642.2 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 43332.62 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 37213.16 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 20406.32 | 4200.9 | 67032.4 | 63480.2 | |||||||||||||||||
income-statement-row.row.operating-expenses | 193054.13 | 190231.2 | 188031.1 | 189481.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 783122.82 | 783122.8 | 800512.7 | 771542.9 | |||||||||||||||||
income-statement-row.row.interest-income | 1731.42 | 1731.4 | 499.5 | 247.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 10672.11 | 10672.1 | 5952.3 | 3288.7 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 37213.16 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -34901.84 | -34901.8 | -76312.7 | -7682.1 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 20406.32 | 4200.9 | 67032.4 | 63480.2 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -34901.84 | -34901.8 | -76312.7 | -7682.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 10672.11 | 10672.1 | 5952.3 | 3288.7 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 15380.48 | 12556.1 | -63218.7 | 8983.2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 34548.17 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 18428.04 | 11590.8 | -7548 | 1552.9 | |||||||||||||||||
income-statement-row.row.income-before-tax | -16473.8 | -23311 | -83860.6 | -6129.2 | |||||||||||||||||
income-statement-row.row.income-tax-expense | -740.82 | -740.8 | -715.6 | 6740.8 | |||||||||||||||||
income-statement-row.row.net-income | -7978.87 | -16249.7 | -83145 | -12870 |
Întrebări frecvente
Ce este Jeil Pharma Holdings Inc (002620.KS) totalul activelor?
Jeil Pharma Holdings Inc (002620.KS) activele totale sunt 879996990707.000.
Care este venitul anual al întreprinderii?
Venitul anual este 395204780875.000.
Care este marja de profit a întreprinderii?
Marja de profit a firmei este 0.264.
Care este fluxul de numerar liber al întreprinderii?
Fluxul de numerar liber este -933.170.
Care este marja de profit net a întreprinderii?
Marja profitului net este -0.010.
Care este venitul total al întreprinderii?
Venitul total este 0.023.
Care este Jeil Pharma Holdings Inc (002620.KS) profitul net (venitul net)?
Profitul net (venitul net) este -16249744239.000.
Care este datoria totală a firmei?
Datoria totală este 173030541501.000.
Care este numărul cheltuielilor de exploatare?
Cheltuielile de exploatare sunt 190231187725.000.
Care este cifra de numerar a firmei?
Numerarul întreprinderii este 37038628042.000.